Cite
HARVARD Citation
Hu, M. et al. (2021). CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry. Bioengineered. 12 (1), pp. 5996-6009. [Online].